Live from the NIH registry
Studies recruiting near Indianapolis right now
Top 25 of 915 recruiting studies, sorted by proximity — each links to its official registry page
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Community Health Network, Inc — Indianapolis, Indiana (0.9 mi)
· Sponsor: Relay Therapeutics, Inc.
AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss
Obesity
Phase 3
Interventional 600 participants sought
Midwest Inst For Clin Res — Indianapolis, Indiana (0.9 mi)
· Sponsor: Novo Nordisk A/S
Point-of-care Ultrasound Utility in the Free Clinic Setting
Point of Care Ultrasound (POCUS)
N/A
Interventional 50 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
Methodist Hospital of Indiana — Indianapolis, Indiana (0.9 mi)
· Sponsor: Cook Research Incorporated
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
Tibial Fractures, Pain
Phase 3
Interventional 1,000 participants sought
Eskenazi Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
Delricht Research - Better Life Direct Primary Care — Indianapolis, Indiana (0.9 mi)
· Sponsor: Crystalys Therapeutics
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Riley Hospital For Children - PIN — Indianapolis, Indiana (0.9 mi)
· Sponsor: Takeda
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck
Phase 1
Interventional 1,006 participants sought
Community Health Network, Inc — Indianapolis, Indiana (0.9 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Type 1 Diabetes Extension Study
Type 1 Diabetes Mellitus, T1DM
N/A
Observational 111 participants sought
Indiana University Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Ondansetron for the Management of Atrial Fibrillation
Atrial Fibrillation
Phase 4
Interventional 80 participants sought
Indiana Clinical Research Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Early Onset Alzheimer Disease, Alzheimer Disease
N/A
Observational 850 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
Dyspareunia, Pelvic Pain
N/A
Interventional 20 participants sought
Indiana University Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
Non-Muscle Invasive Bladder Neoplasms
N/A
Observational 150 participants sought
Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Janssen Research & Development, LLC
Comparison of Uncomplicated Candidemia Therapy Duration in Children
Invasive Candidiasis
N/A
Interventional 420 participants sought
Riley Children's Hospital — Indianapolis, Indiana (0.9 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Prevention/Reduction of ASRs and PTSD to Sustain Civilian Performance With Sublingual Cyclobenzaprine HCl (TNX-102 SL)
Acute Stress Reaction, Acute Stress Disorder
Phase 2
Interventional 180 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: University of North Carolina, Chapel Hill
High vs Low-frequency of High-intensity Training in Chronic Stroke
Stroke
N/A
Interventional 40 participants sought
Rehabilitation Hospital of Indiana — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Atopic Dermatitis
Phase 3
Interventional 180 participants sought
Dawes Fretzin Clinical Research Group, LLC — Indianapolis, Indiana (0.9 mi)
· Sponsor: Organon and Co
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
Growth Hormone Deficiency
N/A
Observational 500 participants sought
Ascendis Investigational Site — Indianapolis, Indiana (0.9 mi)
· Sponsor: Ascendis Pharma Endocrinology Division A/S
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Riley Hospital for Children — Indianapolis, Indiana (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)
Pancreatic Cancer, Chronic Pancreatitis
N/A
Observational 775 participants sought
Indiana University — Carmel, Indiana (14.0 mi)
· Sponsor: M.D. Anderson Cancer Center
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
NonSegmental Vitiligo
Phase 3
Interventional 180 participants sought
Indiana University School of Medicine — Indianapolis, Indiana (0.9 mi)
· Sponsor: Incyte Corporation
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
Caregiver Burden, Alzheimer Disease
N/A
Interventional 184 participants sought
IU Health — Indianapolis, Indiana (0.9 mi)
· Sponsor: Indiana University
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Sickle Cell Disease
Phase 1
Interventional 24 participants sought
Innovative Hematology - Indiana Hemophilia & Thrombosis Center — Indianapolis, Indiana (0.9 mi)
· Sponsor: Disc Medicine, Inc
Stroke Thrombectomy and Aneurysm Registry
Stroke, Thromboses, Intracranial
N/A
Observational 40,000 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Medical University of South Carolina
DILIN - Prospective Study
Liver Diseases
N/A
Observational 4,000 participants sought
Indiana University — Indianapolis, Indiana (0.9 mi)
· Sponsor: Duke University